Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Labenz

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Alimentary Pharmacology & Therapeutics|October 6, 2018
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in GermanyChristian Labenz, Yvonne Huber, Eva Kalliga, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver CirrhosisLeonard Kaps, Lejla Lukac, Maurice Michel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2018
Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic InflammationYvonne Huber, Marie Boyle, Kate Hallsworth, et al.
Journal of Clinical Gastroenterology|November 16, 2018
Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic EncephalopathyChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver CirrhosisEva Maria Schleicher, Wolfgang Maximilian Kremer, Vasiliki Kalampoka, et al.
BMC Cancer|August 2, 2018
Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohortYvonne Huber, Franziska Bierling, Christian Labenz, et al.
European Journal of Internal Medicine|August 23, 2018
Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathyChristian Labenz, Larissa Beul, Gerrit Toenges, et al.
European Journal of Internal Medicine|January 21, 2022
Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosisChristian Labenz, Gerrit Toenges, Ming-Hua Zheng, et al.
European Radiology Experimental|December 12, 2023
Variability of transient elastography-based spleen stiffness performed at 100 HzAngelo Armandi, Talal Merizian, Merle Marie Werner, et al.
Mediators of Inflammation|December 11, 2023
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with CirrhosisLeonard Kaps, Carolina Medina-Montano, Matthias Bros, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Alimentary Pharmacology & Therapeutics|October 6, 2018
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in GermanyChristian Labenz, Yvonne Huber, Eva Kalliga, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver CirrhosisLeonard Kaps, Lejla Lukac, Maurice Michel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2018
Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic InflammationYvonne Huber, Marie Boyle, Kate Hallsworth, et al.
Journal of Clinical Gastroenterology|November 16, 2018
Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic EncephalopathyChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver CirrhosisEva Maria Schleicher, Wolfgang Maximilian Kremer, Vasiliki Kalampoka, et al.
BMC Cancer|August 2, 2018
Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohortYvonne Huber, Franziska Bierling, Christian Labenz, et al.
European Journal of Internal Medicine|August 23, 2018
Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathyChristian Labenz, Larissa Beul, Gerrit Toenges, et al.
European Journal of Internal Medicine|January 21, 2022
Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosisChristian Labenz, Gerrit Toenges, Ming-Hua Zheng, et al.
European Radiology Experimental|December 12, 2023
Variability of transient elastography-based spleen stiffness performed at 100 HzAngelo Armandi, Talal Merizian, Merle Marie Werner, et al.
Mediators of Inflammation|December 11, 2023
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with CirrhosisLeonard Kaps, Carolina Medina-Montano, Matthias Bros, et al.
Pageof 15